European Healthtech startup funding raised during June 2022.
In June 2022, 66 European Healthtech companies raised a combined €927M across 67 funding rounds, up 40.3% versus June 2021. France led by capital raised, and Co-Founders was the most active investor. Data as of 9 Jul 2026.
5 exits · €2.9B disclosed.
| Norgine | Acquisition | Jun 2022 | €1.8B |
| SPT Labtech |
| Acquisition |
| Jun 2022 |
| €757M |
| Normax | IPO | Jun 2022 | €300M |
| €70M |
| Immunos Therapeutics | Series B | Jun 2022 | €68M |
| Transition Bio | Series A | Jun 2022 | €47M |
| Evaxion Biotech | Other | Jun 2022 | €38M |
| Peptone | Other | Jun 2022 | €37M |
| Synklino | Series A | Jun 2022 | €30M |
| Moon Surgical | Series A | Jun 2022 | €30M |
| Birdie | Series B | Jun 2022 | €29M |
| Ariceum Therapeutics | Series A | Jun 2022 | €25M |
| Relation Therapeutics | Seed | Jun 2022 | €24M |
| BioVersys | Series C | Jun 2022 | €23M |
| LynxCare | Series A | Jun 2022 | €20M |
